Join our upcoming webinar to explore how the FDA’s validated translational model was used to evaluate the effectiveness of intranasal nalmefene as a reversal agent, alongside naloxone. Register here: go.slp-marketing.com/2025-01-16-Eva…

In our blog, we dive into real-world case studies that demonstrate how QSP models are transforming drug development—from optimizing dosing strategies to ensuring safety and efficacy in clinical trials. simulations-plus.com/resource/qsp-i…

Researchers cracked the code on how trofinetide—the first-ever approved treatment for Rett syndrome—works for patients with kidney challenges. Using pharmacokinetic modeling, scientists developed a precise dosing approach. Read more here: simulations-plus.com/resource/physi…

For the first time ever, you can design and optimize your drug compounds for efficacy—then prioritize your most promising candidates by likelihood of liver safety concern. Learn more about Liver Safety+. simulations-plus.com/campaign/safet…

Thank you to everyone who came by the booth last week at the 14th Conference on Drug and Chemical Xenobiotic Metabolism (DCXM) in Shanghai! We and our colleagues at PharmoGo look forward to continued conversations and collaborations with you.

In this on-demand webinar, experts from industry and global regulatory agencies weigh in and share their experience and insight about the use of PBPK/PBBM for achieving BCS class 3 biowaivers. Watch this webinar for their insights: youtu.be/SDOLFEyoTjM

SCOPE Summit is coming in sunny Orlando, FL! If you’ll be attending, you won’t want to miss Dr. Brad Stefanovic’s presentations. You can also swing by booth #1208 and meet our team. simulations-plus.com/events/scope-s…

Although the newest generation of weight loss drugs are highly effective, the associated nausea patients often experience can deter them from proper adherence. Luckily, OBESITYsym is now available to help researchers develop effective treatments. simulations-plus.com/software/obesi…

What if model building was as fast as your thinking? What if you could implement a model as soon as you developed a hypothesis? In this blog post, Monika Twarogowska explains how Monolix makes these dreams a reality. Read it here: simulations-plus.com/resource/less-…

Millions of virtual drug candidates, optimized for activity, synthesizability, ADMET & PK/tissue selectivity properties--with fewer, faster cycles. Accelerate the DMTA process. simulations-plus.com/campaign/evolv…

Thank you to everyone who stopped by to chat last week at The 4th Forum on Methodology and Technology of Clinical Trials in Shanghai. We and our colleagues at Pharmogo always appreciate the chance to meet you in person.

What was everyone else reading in 2024? Don’t be left in the dark. We’ve gathered the 10 journal articles from our Resource Center that were most read this year, and made them available for you in one place. simulations-plus.com/resource/10-mo…

Whether you're a drug discovery scientist striving to create high-quality lead compounds or a toxicologist ensuring product safety across industries, our tutorial series will guide you step-by-step in harnessing the full potential of ADMET Predictor. youtube.com/playlist?list=…

Wishing our clients around the world a joyful holiday season filled with peace, happiness, and success. Thank you for your continued support – we look forward to achieving even greater things together in 2025. Happy Holidays from our team to yours!

We love seeing Monolix® used for innovative research like this, allowing for a deeper understanding of how surgical interventions like RYGB can alter drug pharmacokinetics and ultimately lead to more precise, effective treatments! Read more: simulations-plus.com/resource/redef…

Join our upcoming webinar to explore how the FDA’s validated translational model was used to evaluate the effectiveness of intranasal nalmefene as a reversal agent, alongside naloxone. Register here: go.slp-marketing.com/2025-01-16-Eva…

"Multiple simultaneous simulations open up a lot of possibilities." Can your PBPK platform run multiple simulations at once? GastroPlus® X can. See how it stacks up to the competition. simulations-plus.com/software-evalu…

With Panorama, you can strategically prioritize the key opinion leaders you want to engage, track their sentiments about your therapy’s key messages, and discover the events they’ll be attending, Learn more: simulations-plus.com/software/panor…

Register to join us for our webinar, where Dr. Susie Zhang, Vice President of Regulatory Strategies, will explain how in silico methods can streamline DDI research and significantly reduce the time and need for expensive study-based clinical trials go.slp-marketing.com/02-04-25-DDI-R…

Clinical trials are costly. Adaptive learning can help identify potential problems with protocol adherence before study initiation—and before they impact your timeline or budget. Curious how? Watch this 3-minute case study to learn how. youtu.be/uivo8WxWs_s?si…